Cover Image
市場調查報告書

動物用疫苗的全球市場

Veterinary Vaccines

出版商 Global Industry Analysts, Inc. 商品編碼 236741
出版日期 內容資訊 英文 306 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
動物用疫苗的全球市場 Veterinary Vaccines
出版日期: 2016年05月01日 內容資訊: 英文 306 Pages
簡介

本報告是針對動物用疫苗的全球市場,包含2013-2020年期間中的市場總值與寵物用(狗、貓)、家畜用(豬、牛、鳥類、羊、馬等)等的產品分類分析。以及美國、歐洲等地的預測及調查。分析過去7年間的市場變化以及提供各家參與企業共100間的資料與其關係性,概述如下:

第1章 導論、調查方法、產品的定義

  • 調查的可信度與報告的範圍
  • 免責聲明
  • 數據解說與報告等級
    • 定量技術與分析
  • 產品的定義與調查範圍
    • 寵物用疫苗
    • 家畜用疫苗
      • 豬疫苗
      • 牛疫苗
      • 鳥類疫苗
      • 羊疫苗
      • 馬疫苗
      • 其他動物用疫苗

第2章 摘要

  • 市場概說與展望
    • 新型動物疾病的出現加速了動物疫苗的全球市場
    • 市場分析
    • 科學的研究開發是市場的必需品
    • 「成熟市場」對「新興市場」
    • 市場課題
    • 內涵強硬的市場
  • 市場的動向與課題
    • 動搖市場的基因改造技術
    • 動物疫苗傳遞系統和簡易免疫佐劑的使用
    • 口蹄疫(FMD)因為疫苗而受制:全球進程
    • 通過開發改善的輔助用炭疽與狂犬病等其他疫苗
    • 開發中國家的高度成長辦隨著寵物用疫苗的需求
    • 疫苗過度使用造成有害的傾向
    • 人類疫苗施設中用雞蛋培養的動物用疫苗
    • 預防人畜共通感染症需要更多種的疫苗
    • 鳥類疫苗市場的開展
    • 未來性的寄生蟲疫苗
    • 影響家畜疫苗市場的價格設定
    • 店舖販賣(OTC)市場:有可能影響到獸醫
    • 疫苗接種 – 阻止禽流感的必要條件之一
  • 產品概要
    • 疫苗 - 進化的足跡
    • 獸醫學 - 概略說明
    • 發展概念
    • 疫苗的生產
    • 動物用疫苗 - 動物健康管理的必需品
    • 動物用疫苗的作用
    • 動物用疫苗的分類
    • 寵物用疫苗
      • 狗疫苗
      • 貓疫苗
    • 家畜疫苗
      • 牛疫苗
      • 雞疫苗
      • 羊疫苗
      • 豬疫苗
      • 馬疫苗
      • 水產養殖疫苗
    • 疫苗可以抑制的主要動物疾病與分析
    • 給予疫苗後的反應
    • 動物用疫苗 - 最近的大發見
    • 標記/DIVA(受感染個體識別和已經接種疫苗個體)疫苗
    • DNA疫苗
    • 基因缺失疫苗
    • 病毒向量化疫苗
  • 主要動物疾病
    • 布魯氏菌病 □□□
    • 肺結核 □□□
    • 副結核病 □□□
    • 螺旋體相關的疾病 □□□
    • 山羊,綿羊,牛特定的呼吸道疾病 □□□
    • 豬的呼吸道疾病 □□□
    • 乳腺炎 □□□
    • 非洲豬霍亂 □□□
    • 禽流感 □□□
    • 東海岸熱病 □□□
    • 出血性敗血症 □□□
    • 手足口病 □□□
    • 日本腦炎 □□□
    • 裂谷熱 □□□
    • 馬特定的病毒感染
  • 產品發售、技術革新
  • 最近的產業活動
  • 全球的主要相關企業
  • 全球市場分析

第3章 市場

  • 美國
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 英國
    • 其他國家
  • 亞洲大洋州
    • 中國
    • 其他國家
  • 中南美
  • 其他

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-1129

This report analyzes the worldwide markets for Veterinary Vaccines in US$ by the following Product Segments: Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines). The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 102 companies including many key and niche players such as -

Bayer HealthCare AG
Biogenesis Bago
Boehringer Ingelheim GmbH
Ceva Sante Animale
Elanco Animal Health

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • A. Companion Animal Vaccines
    • B. Livestock Vaccines
        • Porcine Vaccines
        • Bovine Vaccines
        • Poultry Vaccines
        • Ovine Vaccines
        • Equine Vaccines
        • Other Animal Vaccines

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW & OUTLOOK

  • Emergence of Newer Animal Diseases Drives the Global Veterinary Vaccines Market
    • Table 1: Global Animal Health Products Market by Product Group (2013): Percentage Share Breakdown by Value sales for Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives and Other Pharmaceuticals (includes corresponding Graph/Chart)
    • Table 2: Global Animal Health Products Market by Region (2013): Percentage Share Breakdown by Value Sales for North America, Europe, Latin America and Rest of World (includes corresponding Graph/Chart)
  • Market Outlook
  • Scientific R&D - Crucial for Market Growth
  • Mature Markets Vis-a-vis Emerging Markets
  • Market Challenges
  • A Highly Consolidated Market

2. MARKET TRENDS & ISSUES

  • Recombinant DNA Technology to Take Over the Industry
  • Improvised Adjuvant Usage and Veterinary Vaccine Delivery Systems
  • Global Efforts to Conquer FMD by an Effective Vaccine
  • Anthrax, Rabies, and Other Vaccines with Improved Adjuvants in the Pipeline
  • Pet Vaccines Trailing on a High Growth Track in Developing Countries
  • Over-Vaccination Trend May Prove Harmful
  • Egg-Derived Veterinary Vaccines in Human Vaccine Facilities
  • More Vaccines Needed to Prevent Zoonotic Infections
  • Developments in the Poultry Vaccine Market
  • Parasitic Vaccines Segment Holds Potential
  • Pricing Affects the Livestock Vaccine Market
  • OTC Market: A Potential Threat for Veterinarians
  • Vaccination - Critical for Controlling Avian Influenza Virus

3. PRODUCT OVERVIEW

  • Vaccines - An Evolutionary Scan
  • Veterinary Medicines - A Brief Review
  • Concept Development
  • Production of Vaccines
  • Veterinary Vaccines - An Essential Component of Animal Healthcare
  • What Does A Veterinary Vaccine Do?
  • Classification of Veterinary Vaccines
  • Companion Animal Vaccines
    • Canine Vaccines
      • Canine Distemper
      • Canine Parvovirus
      • Tracheobronchitis
      • Canine Coronavirus
      • Canine Leptospirosis
      • Canine Giardia
      • Canine Lyme borreliosis
      • Canine Rabies
    • Feline Vaccines
      • Feline Panleukopenia Virus Vaccine
      • Feline Calicivirus & Herpesvirus Vaccine
      • Rabies Virus Vaccine
      • Feline Leukemia Virus Vaccine
      • Chlamydia, Feline Infectious Peritonitis, and Ringworm Vaccines
  • Livestock Vaccines
    • Bovine Vaccines
      • Bovine virus diarrhoea - Mucosal disease (BVD-MD)
      • Johne's disease
      • Infectious Bovine Rhinotracheitis (IBR)
      • Blackleg
      • Neosporosis
    • Poultry Vaccines
    • Ovine Vaccines
    • Porcine Vaccines
    • Equine Vaccines
    • Aquaculture Vaccines
  • A Tabular Analysis on Select Animal Diseases Controlled by Vaccines
  • Vaccination and Its Reactions
  • Veterinary Vaccines- Latest Breakthroughs
  • Marker/DIVA Vaccines
  • DNA Vaccines
  • Gene-Deleted Vaccines
  • Viral-Vectored Vaccines

4. NOTES ON SELECT ANIMAL DISEASES

  • Brucellosis
  • Tuberculosis
  • Johne's disease II-22 Spirochete Associated Diseases
  • Respiratory Disease in Goats, Sheep, and Cattle
  • Porcine Respiratory Diseases
  • Mastitis
  • African swine fever
  • Avian Influenza
  • East Coast Fever
  • Hemorrhagic Septicemia
  • Foot-And-Mouth Disease
  • Japanese Encephalitis
  • Rift Valley Fever
  • Equine Virus Infection

5. PRODUCT LAUNCHES AND INNOVATIONS

  • Ceva Animal Health Vietnam Unveils Hyogen(r)
  • Merck Introduces SE Guard(tm) Vaccine against Salmonella Enteritidis
  • Hygieia Biological Unveils New Vaccine for Streptococcus Mastitis
  • MSD Animal Health Announces Bovilis IBR Marker Inac
  • BIVI Launches New VETERA(r) XP Vaccine Range
  • BIVI Launches FLEXcombo(r) Vaccine
  • Merck Animal Health Launches Circumvent PCV G2 Vaccine
  • MSD Animal Health Introduces New Equilis Prequenza Vaccine
  • Zoetis Launches Bovi-Shield Gold One Shot(tm) Respiratory Vaccine
  • MSD Animal Health Introduces Nobivac L4 Vaccine
  • Merck Animal Health Unveils Vetsulin(r)
  • Bayer Unveils Serersto(tm) Flea- and Tick- Collar for Cats and Dogs
  • MSD Animal Health Introduces INNOVAX(r)-ND-SB in India
  • Zoetis Launches Fostera PCV MH Combination Vaccine
  • Boehringer Ingelheim Vetmedica Launches Vaccine for ERAV
  • Merck Animal Health Launches Bron-Newcavac-SETM
  • Pfizer Animal Health Introduces Poulvac E Coli
  • Ceva Sante Animale Launches Vectormune(r) AI
  • Newport Laboratories Introduces ParaSail(r)
  • Novartis Animal Health Launches BRD Shield
  • Ceva Animal Health Launches CEVAC(r) CORYMUNE 7K and CEVAC(r) CORYMUNE 4K
  • Pfizer Introduces Equivac(r) HeV Vaccine
  • BIVI Unveils New Generation Canine Vaccine Line
  • Merial Animal Health Introduces New Pack Size of Circovac Vaccine
  • MSD Animal Health Unveils New Vaccine for Goats and Sheep
  • Virbac Launches First Vaccine in EU for Canine Leishmaniosis
  • Yissum Research and Development Announces Production of Vaccine to Offer Protection against CME
  • Virbac Introduces Bovidec
  • Intervet/Schering-Plough Animal Health Introduces a New Web Site for Innovax recombinant Vaccines Product Line
  • Pfizer Animal Health Introduces the First E. Coli Bacterial Extract Vaccine
  • Intervet/Schering-Plough Unveils BacuCheck(tm) ELISA Test
  • Merck Unveils Coccivac(r)-D2 Poultry Vaccine
  • Merck Animal Health Introduces NOBIVAC(r) Myxo-RHD Vaccine
  • Pfizer Animal Health Canada Introduces Fostera(tm) PCV Vaccine
  • Brentec Vaccines Introduces Poultry Vaccine
  • Intervet/Schering-Plough Animal Health Launches Atrophic Rhinitis Vaccine for Pigs
  • Merial Introduces VAXXITEK HVT + IBD Vaccine
  • Agrilabs Introduces MpB Cattle Vaccine
  • Ceva Launches New VECTORMUNE HVT-NDV(r) Poultry Vaccine

6. RECENT INDUSTRY ACTIVITY

  • Elanco Inks Agreement to Take Over Assets of Lohmann SE and Lohmann Animal Health
  • Biogenesis Bago to Construct FMD Vaccine Facility in China
  • Boehringer Ingelheim Teams Up with Taizhou China Medical City to Construct Veterinary Vaccines Production Plant
  • Heska Acquires 54.6% Majority Stake in Cuattro Veterinary USA
  • Harrisvaccines Expands Its License Agreement with Alphavax to Include Companion Animal Vaccines
  • AgriLabs Secures USDA Approval for Pulmo-Guard Vaccine for Cattle
  • IDT Acquires Assets of Riemser Pharma
  • MWI Veterinary Supply Acquires Assets of IVESCO Holdings
  • Imaxio Enters into R&D partnership agreement with VitamFero
  • Elanco Animal Health Signs Distribution Agreement for Prevtec's Swine Vaccine
  • Valneva and Boehringer Ingelheim Ink Research License Agreement
  • Imaxio Inks Agreement with Leading Animal Health Laboratory
  • Heska Divests Assets to Elanco Animal Health
  • Bayer Expands its Centre for Innovation and Development
  • Bayer HealthCare Receives FDA Approval to Market ProstaMate(tm) and OvaCyst(tm)
  • MSD Presents Data Regarding Porcilis(r) Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
  • Merck Animal Health's Vista(r) MLV Vaccine Line Gets USDA Approval
  • Harrisvaccines Expands License Agreement with AlphaVax
  • Virbac Gets Limited Marketing Authorization for Gudair(r)
  • Merial Receives Exceptional Approval for Schmallenberg Vaccine in France
  • Zoetis China JV Receives Approval for Swine Vaccine
  • Vetanco Secures Approval from SENASA for BiotechVac Vaccine
  • Intercell Merges with Vivalis
  • Tianjin Ringpu Bio-technology Secures Approval from Ministry of Agriculture for Porcine Circovirus Type 2 Vaccine
  • Merial Korea Chusik Hoesa and Special Vaccine Ink Contract
  • Elanco Animal Health to Take Over Master Guard and Titanium Vaccine Brands of AgriLabs
  • Pfizer Animal Health Renames Escherichia coli Mastitis Vaccine to ENVIRACOR J-5
  • Global Green Awaits USDA Approval for Salmogenics Vaccine
  • Pfizer to Restructure Indian Animal Health Unit
  • Lohmann Animal Health Establishes Lohmann Animal Health Mexico
  • DSM and Merial Sign Collaboration Agreement for Producing Algae Based Vaccines
  • Heska Enters into Distribution Partnership with MWI Veterinary Supply
  • Bayer HealthCare Inks Agreement to Acquire KMG Chemicals' Animal Health Business
  • Pfizer's Equivac HeV Vaccine for Equines Granted APVMA Approval
  • Boehringer Ingelheim to Expand Porcine Vaccines' Production Capacity
  • BIVI Launches Bronchi-Shield ORAL
  • Sanofi Inks Agreement to Take Over Animal Health Division of Dosch Pharmaceuticals
  • Hester Biosciences and Innoves Animal Health Ink Business Transfer Agreement
  • Benchmark Holdings Acquires Braintree Vaccine Manufacturing Plant of Novartis Animal Health
  • Merial Takes Over Newport Laboratories
  • Delphi Announces Successful Application of Staby [R] Technology to DNA Vaccine In-Vivo Testing
  • FATRO and VIVALIS Ink Agreement
  • Kitasato Daiichi Sankyo Vaccine to Discontinue Animal Vaccine Business
  • Merial Unveils PUREVAX(r) Recombinant FeLV
  • Merck Animal Health Develops Vaccine for Schmallenberg Virus
  • Antelope Valley Bios Secures Conditional License from United States Department of Agriculture
  • Pfizer Animal Health Expands its R&D Global Headquarters
  • Merck Renames Intervet/Schering-Plough Animal Health as Merck Animal Health
  • Sanofi and Merck to Operate Separate Animal Health Businesses
  • Centegen Inks Licensing Agreement with Merial for CEN-102 Staphylococcal Vaccine
  • Pfizer Poultry Health Acquires Alpharma
  • Virbac and Schweitzer Biotech to form Joint Venture SBC-Virbac
  • Pfizer Animal Health Enters into Agreement with Jilin Guoyuan Animal Health
  • Cadila Healthcare Acquires Bremer Pharma
  • IVRI Inks MoU with University of Glasgow and Moredun Research Institute
  • Vivalis and Kyoto Biken Laboratories Enter into Commercial Licensing Agreement
  • Xinjiang Tecon Animal Husbandry Biotechnology and Taiwan Maoxing Biotechnology Ink Licensing Agreement
  • The Ugandan Government Enters into Partnership with Brentec Vaccines International
  • Malaysian Government to Collaborate with Maryland University
  • Bioniche Life Sciences Sets up Vaccine Manufacturing Unit
  • Bayer Obtains European Commission's Approval for Veraflox(r) and Procox(r)
  • MSD Expands Elkhorn Biotechnology Excellence Center's Vaccination Unit
  • Hester Biosciences and Him Electronics Enter into Collaboration
  • Boehringer Ingelheim Secures Approval in Europe
  • Tangshan Yian Biological Engineering Secures Production License from Ministry of Agriculture for RabEnd
  • Merck Animal Health Secures Regulatory Approval to Commercialize AQUAVAC(r) Strep Sa Vaccine in Brazil

7. FOCUS ON SELECT GLOBAL PLAYERS

  • Bayer HealthCare AG (Germany)
  • Biogenesis-Bago (Argentina)
  • Boehringer Ingelheim GmbH (Germany)
  • Ceva Sante Animale (France)
  • Heska Corporation (US)
  • Indian Immunologicals Ltd (India)
  • Lohmann Animal Health (US)
  • Merck Animal Health (US)
  • Merial Ltd. (US)
  • Protein Sciences Corporation (US)
  • Virbac SA (France)
  • Zoetis Inc. (US)

8. GLOBAL MARKET PERSPECTIVE

    • Table 3: World Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 4: World Historic Review Veterinary Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 5: World 15-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 6: World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 7: World Historic Review for Companion Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 8: World 15-Year Perspective for Companion Animal Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 9: World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Product Segment - Canine Vaccines and Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 10: World Historic Review for Companion Animal Vaccines by Product Segment - Canine Vaccines and Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 11: World 15-Year Perspective for Companion Animal Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Canine Vaccines & Feline Vaccines Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 12: World Recent Past, Current & Future Analysis for Canine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 13: World Historic Review for Canine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 14: World 15-Year Perspective for Canine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 15: World Recent Past, Current & Future Analysis for Feline Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 16: World Historic Review for Feline Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 17: World 15-Year Perspective for Feline Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 18: World Recent Past, Current & Future Analysis for Livestock Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 19: World Historic Review for Livestock Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 20: World 15-Year Perspective for Livestock Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 21: World Recent Past, Current & Future Analysis for Livestock Vaccines by Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 22: World Historic Review for Livestock Vaccines by Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 23: World 15-Year Perspective for Livestock Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 24: World Recent Past, Current & Future Analysis for Porcine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 25: World Historic Review for Porcine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 26: World 15-Year Perspective for Porcine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 27: World Recent Past, Current & Future Analysis for Bovine Vaccines by Geographic Region - US, Europe & Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 28: World Historic Review for Bovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 29: World 15-Year Perspective for Bovine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 30: World Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 31: World Historic Review for Poultry Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 32: World 15-Year Perspective for Poultry Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 33: World Recent Past, Current & Future Analysis for Ovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 34: World Historic Review for Ovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 35: World 15-Year Perspective for Ovine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 36: World Recent Past, Current & Future Analysis for Equine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 37: World Historic Review for Equine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 38: World 15-Year Perspective for Equine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 39: World Recent Past, Current & Future Analysis for Other Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 40: World Historic Review for Other Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 41: World 15-Year Perspective for Other Animal Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Food Safety Concerns and Biotechnological Offerings Drive the Vaccine Market
    • Dogs and Cats Obesity Vaccines Receive First US Patent
    • H5N1 Virus: A Conundrum for the US Industry
    • Product launches
    • Strategic Corporate Developments
    • Select Major Players
  • B. Market Analytics
    • Table 42: The US Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/ Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 43: The US Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 44: The US 15-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

2. EUROPE

  • A. Market Analysis
    • Steady Market Growth Expected Due to Superior Livestock Management
    • Regulations
    • EU Animal Welfare Strategy
    • Product Launches and Innovations
    • Strategic Corporate Developments
    • Select Major Players
  • B. Market Analytics
    • Table 45: European Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 46: European Historic Review for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 47: European 15-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 48: European Recent Past, Current & Future for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 49: European Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 50: European 15-Year Perspective for Veterinary Vaccines by Product Group/ Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

2a. FRANCE

  • A. Market Analysis
    • Product Launches and Innovations
    • Strategic Corporate Developments
    • Select Major Players
  • B. Market Analytics
    • Table 51: French Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 52: French Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 53: French 15-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

2b. GERMANY

  • A. Market Analysis
    • Strategic Corporate Developments
    • Select Major Players
  • B. Market Analytics
    • Table 54: German Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 55: German Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 56: German 15-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

2c. ITALY

  • A. Market Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 57: Italian Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 58: Italian Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 59: Italian 15-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

2d. SPAIN

  • Market Analysis
    • Table 60: Spanish Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 61: Spanish Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 62: Spanish 15-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

2e. THE UNITED KINGDOM

  • A. Market Analysis
    • Product Launches and Innovations
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 63: The UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 64: The UK Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 65: The UK 15-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

2f. REST OF EUROPE

  • A. Market Analysis
    • A Review of Select Regional Markets
      • The Netherlands
      • Denmark
      • Russia Mass-Produces Vaccines against Avian Flu
  • B. Market Analytics
    • Table 66: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 67: Rest of Europe Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 68: Rest of Europe 15-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

3. ASIA-PACIFIC

  • A. Market Analysis
    • Product Launches and Innovations
    • Strategic Corporate Developments
    • Select Key Player
      • Indian Immunologicals Ltd. (India)
  • B. Market Analytics
    • Table 69: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Vaccines by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 70: Asia-Pacific Historic Review for Veterinary Vaccines by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 71: Asia-Pacific 15-year Perspective for Veterinary Vaccines by Region - Percentage Breakdown of Dollar Sales for China and Rest of Asia-Pacific Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

3a. CHINA

  • A. Market Analysis
    • Increased Livestock Output and Emerging Pet Industry Lead to Higher Vaccine Demand
    • Growing Pet Industry Holds Promise
    • Threat of Avian Influenza Outbreaks Creates Market for Effective Vaccine
    • Demand for Higher-Quality Swine Fever Vaccine
    • Demand for Effective PRRS Vaccines by Foreign Manufacturers
    • FMD Epidemics Cause Increased demand for Vaccine
    • Effective Rabies Vaccine Needed to Curb Dog Menace
    • Highly Consolidated Chinese Veterinary Market
    • Product Launch
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 72: Chinese Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Segment - Porcine Vaccines, Poultry Vaccines, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 73: Chinese Historic Review for Veterinary Vaccines by Product Segment - Porcine Vaccines, Poultry Vaccines, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 74: Chinese 15-Year Perspective for Veterinary Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Porcine Vaccines, Poultry Vaccines, and Other Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

3b. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Focus on Select Regions
      • India
      • Major Players
      • Indigenous Bird Flu Vaccine by ICAR
      • North Korea
      • Taiwan
      • Taiwan's Animal Healthcare Industry under Scan
      • Australia
      • A Note on Australian Veterinary Therapeutics Market
      • Vietnam
      • Vietnam Imports Bird Flu Vaccines
    • Product Launches and Innovations
    • Strategic Corporate Developments
    • Select Key Player
  • B. Market Analytics
    • Table 75: Rest of Asia-Pacific Recent Past, Current & Future Market Analysis for Veterinary Vaccines in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 76: Rest of Asia-Pacific Historic Review for Veterinary Vaccines in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

4. LATIN AMERICA

  • A. Market Analysis
    • Strategic Corporate Developments
    • Biogenesis-Bago - A Key Argentinian Player
  • B. Market Analytics
    • Table 77: Latin American Recent Past, Current & Future Analysis for Veterinary Vaccines by Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 78: Latin American Historic Review for Veterinary Vaccines by Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 79: Latin American 15-year Perspective for Veterinary Vaccines by Region - Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin America Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5. REST OF WORLD

  • A. Market Analysis
    • Focus on Select Regions
      • Canada
      • Overview of the Canadian Animal Health Industry
      • Imports and Manufacture of Veterinary Biologics
      • First to Access E. coli 0157:H7 Vaccine
    • Product Launches and Innovations
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 80: Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 81: Rest of World Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 82: Rest of World 15-Year Perspective for Veterinary Vaccines by Product Group/ Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top